These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21166949)

  • 1. Ceftriaxone-associated cholelithiasis: 30 min drip infusion versus bolus injection.
    Dinleyici EC; Bor O; Kebapci M; Aydogdu SD
    Pediatr Int; 2010 Dec; 52(6):890. PubMed ID: 21166949
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection.
    Arguedas A; Cespedes J; Botet FA; Blumer J; Yogev R; Gesser R; Wang J; West J; Snyder T; Wimmer W;
    Int J Antimicrob Agents; 2009 Feb; 33(2):163-7. PubMed ID: 18945594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia.
    File TM; Low DE; Eckburg PB; Talbot GH; Friedland HD; Lee J; Llorens L; Critchley I; Thye D
    Clin Infect Dis; 2010 Dec; 51(12):1395-405. PubMed ID: 21067350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multicenter, Randomized, Observer-blinded, Active-controlled Study Evaluating the Safety and Effectiveness of Ceftaroline Compared With Ceftriaxone Plus Vancomycin in Pediatric Patients With Complicated Community-acquired Bacterial Pneumonia.
    Blumer JL; Ghonghadze T; Cannavino C; O'Neal T; Jandourek A; Friedland HD; Bradley JS
    Pediatr Infect Dis J; 2016 Jul; 35(7):760-6. PubMed ID: 27078119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The choice of antibacterial drugs.
    Med Lett Drugs Ther; 1999 Oct; 41(1064):95-104. PubMed ID: 10548955
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cholelithiasis associated with the use of ceftriaxone].
    Costa DL; Barbosa MD; Barbosa MT
    Rev Soc Bras Med Trop; 2005; 38(6):521-3. PubMed ID: 16410930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ceftriaxone-induced cholelithiasis--a harmless side-effect?].
    Riccabona M; Kerbl R; Schwinger W; Spork D; Millner M; Grubbauer HM
    Klin Padiatr; 1993; 205(6):421-3. PubMed ID: 8309205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftriaxone-associated gallbladder lithiasis in children.
    Stabile A; Ferrara P; Marietti G; Maresca G
    Eur J Pediatr; 1995 Jul; 154(7):590. PubMed ID: 7556332
    [No Abstract]   [Full Text] [Related]  

  • 9. The choice of antibacterial drugs.
    Med Lett Drugs Ther; 1998 Mar; 40(1023):33-42. PubMed ID: 9549552
    [No Abstract]   [Full Text] [Related]  

  • 10. Ceftaroline fosamil for treatment of community-acquired pneumonia: findings from FOCUS 1 and 2 and potential role in therapy.
    DiMondi VP; Drew RH; Chen LF
    Expert Rev Anti Infect Ther; 2011 Aug; 9(8):567-72. PubMed ID: 21819323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the pharmacokinetics of Aspen Ceftriaxone and Rocephin in community-acquired meningitis.
    Richards GA; Elliott E; Shaddock EJ; Mushi D; Mzileni M; Ray R; Rulisa S; Seolwane F; Stacey SL; Stoltz A; Venturas JP; Schoeman H
    S Afr Med J; 2013 Sep; 103(12):906-9. PubMed ID: 24300626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ceftriaxone: whether there is future for it?].
    Sidorenko SV
    Antibiot Khimioter; 2006; 51(8):3-9. PubMed ID: 18030778
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of Stomatococcus mucilaginosus meningitis with intravenous vancomycin and intravenous ceftriaxone.
    Park MK; Khan J; Stock F; Lucey DR
    Clin Infect Dis; 1997 Feb; 24(2):278. PubMed ID: 9114169
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ceftriaxone-associated biliary pseudolithiasis in a child with nephrotic syndrome].
    Zheng FY; Xing Y; Lu S; Liu DM
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Aug; 15(8):696-7. PubMed ID: 23965889
    [No Abstract]   [Full Text] [Related]  

  • 15. Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
    Torres A; Garau J; Arvis P; Carlet J; Choudhri S; Kureishi A; Le Berre MA; Lode H; Winter J; Read RC;
    Clin Infect Dis; 2008 May; 46(10):1499-509. PubMed ID: 18419482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of correct parenteral antibiotic initiation and outcomes from severe bacterial community-acquired pneumonia in children.
    Muszynski JA; Knatz NL; Sargel CL; Fernandez SA; Marquardt DJ; Hall MW
    Pediatr Infect Dis J; 2011 Apr; 30(4):295-301. PubMed ID: 21030885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftriaxone combination therapy versus respiratory fluoroquinolone monotherapy for community-acquired pneumonia: A meta-analysis.
    Zhang YQ; Zou SL; Zhao H; Zhang MM; Han CL
    Am J Emerg Med; 2018 Oct; 36(10):1759-1765. PubMed ID: 29499898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary precipitation during ceftriaxone therapy: frequency and risk factors.
    Soysal A; Eraşov K; Akpinar I; Bakir M
    Turk J Pediatr; 2007; 49(4):404-7. PubMed ID: 18246742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults.
    Ortiz-Ruiz G; Caballero-Lopez J; Friedland IR; Woods GL; Carides A;
    Clin Infect Dis; 2002 Apr; 34(8):1076-83. PubMed ID: 11914996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ceftriaxone-associated biliary pseudolithiasis in a child].
    Wang YQ
    Zhonghua Er Ke Za Zhi; 2005 Apr; 43(4):251. PubMed ID: 15924712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.